TNNI3K has been shown in several in vitro and transgenic animal studies to promote adaptive and maladaptive cardiac hypertrophy by increasing cardiomyocyte area and sarcomere organization [82]. The gene discussed is TNNI3K; the disease is cardiac hypertrophy.